India’s pharmaceutical packaging market to reach US$4.2B by 2033, Allied Market Research

INDIA – India’s pharmaceutical packaging market is poised for significant growth, driven by the expansion of the country’s pharmaceutical sector and increasing demand for safe and efficient packaging solutions.

According to Allied Market Research, the market was valued at approximately US$1.8 billion in 2023 and is projected to reach US$4.2 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2033.

Several factors contribute to this rapid growth. One key driver is the widespread adoption of blister packaging, which is gaining popularity due to its cost-effectiveness, product protection, and ability to enhance patient compliance by clearly displaying dosage information.

Additionally, the expansion of cold-chain logistics is fueling demand for specialized packaging that ensures the stability of temperature-sensitive drugs such as biologics and vaccines.

India’s role as a major exporter of pharmaceuticals has also heightened the importance of stringent packaging standards to combat counterfeiting.

The implementation of anti-counterfeiting measures, including tamper-evident seals and unique identification codes, is helping to secure product authenticity and strengthen consumer trust.

Furthermore, government initiatives and increased healthcare spending are supporting the industry’s growth.

In the financial year 2023, the Indian government allocated 2.6% of the GDP to healthcare, with a projected expenditure of 2.5% for 2025.

These investments are expected to bolster pharmaceutical production and, in turn, drive the need for advanced packaging solutions.

The market is segmented based on product type and material type. Among product types, parenteral containers such as vials, ampoules, and cartridges are widely used for injectable drugs.

Plastic bottles remain a staple for solid and liquid oral medications, while blister packaging continues to be preferred for unit-dose applications.

Other key segments include specialty bags, closures, and labeling solutions. In terms of materials, glass is commonly used for its inert properties, while aluminum foils offer excellent barrier protection in blister packs.

Plastics and polymers such as HDPE, PET, and PP dominate due to their durability and flexibility, while paper and paperboards are primarily used for labeling and secondary packaging.

Key players in India’s pharmaceutical packaging market include CCL Industries Inc., West Pharmaceutical Services, Berry Global Group, Catalent Inc., Gerresheimer AG, SCHOTT Pharmaceutical Packaging, Amcor plc, Aptar Group, Nipro Corporation, and BD (Becton, Dickinson and Company).

These companies are leveraging innovation and sustainability to stay competitive and meet evolving industry demands. 

Despite its promising trajectory, the market faces challenges related to sustainability. The heavy reliance on plastic packaging has raised environmental concerns, prompting companies to explore biodegradable and recyclable alternatives.

However, high costs and limited availability of eco-friendly materials remain significant barriers. Nevertheless, the growing focus on green packaging solutions presents long-term opportunities for the industry, with companies increasingly investing in sustainable innovations. 

As India’s pharmaceutical packaging sector continues to expand, advancements in packaging technology, regulatory compliance, and sustainable practices will be crucial in shaping the industry’s future.

By addressing emerging challenges and adapting to evolving market demands, the sector is well-positioned to ensure the safe and efficient delivery of pharmaceutical products worldwide.

Subscribe to our email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE